.png){kind=icon}
.png){kind=icon}
Return
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
.png){kind=icon}
PRE
AI
DOI：10.1016/j.eururo.2025.09.007.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
We aimed to assess the comparative effectiveness of contemporary systemic treatment options across patients with metastatic hormone-sensitive prostate cancer (mHSPC) across clinically relevant prognostic subgroups (synchronous high [SHV] and low [SLV] volume, and metachronous high [MHV] and low [MLV] volume).
Journal
IF:
25.2
Papers:
1.2W
Citations:
3.7W
Organization
View more organizations